The same research group could show in a study focusing on paxillin and protein tyrosine phosphatase receptor T (PTPRT) in CRC that phosphorylated Y88 in paxillin impacts the AKT pathway by controlling the interaction of the p85 regulatory PI3K subunit and p130Cas [26]. The gene discussed is PXN; the disease is colorectal carcinoma.